-
1 Comment
Shanghai Fosun Pharmaceutical (Group) Co., Ltd is currently in a long term uptrend where the price is trading 21.5% above its 200 day moving average.
From a valuation standpoint, the stock is 64.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.4.
Shanghai Fosun Pharmaceutical (Group) Co., Ltd's total revenue rose by 11.5% to $8B since the same quarter in the previous year.
Its net income has dropped by 5.9% to $1B since the same quarter in the previous year.
Finally, its free cash flow fell by 411.9% to $-1B since the same quarter in the previous year.
Based on the above factors, Shanghai Fosun Pharmaceutical (Group) Co., Ltd gets an overall score of 3/5.
Sector | Healthcare |
---|---|
Industry | Drug Manufacturers - Specialty & Generic |
Exchange | SHG |
CurrencyCode | CNY |
ISIN | CNE000000X38 |
PE Ratio | 24.04 |
---|---|
Market Cap | 73B |
Beta | 0.69 |
Target Price | 27.03 |
Dividend Yield | 1.0% |
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. manufactures, distributes, and sells pharmaceutical products in Mainland China and internationally. The company offers pharmaceutical products for oncology and immunomodulation, metabolism and digestive system, anti-infection, central nervous system, and cardiovascular system; and APIs and intermediates, including amino acid, tranexamic acid, levamisole hydrochloride, and clindamycin hydrochloride. It also provides mRNA vaccines for Covid-19; medical devices for medical cosmetologym personal care, dentistry, injection filling, respiratory health, mobile pre-hospital care, professional in-hospital surgery, and surgical robots and medical consumables for pre-hospital emergency, neurosurgery, orthopedics, and oncology fields; and solutions for biochemical, immune, molecular, microbiological, and pathological diagnosis, as well as chronic care management. In addition, the company offers online and offline medical services, such as pharmaceuticals and medical devices, consumer healthcare and healthcare commodities, and other comprehensive commodities; specialized medical treatment; and insurance services. The company was founded in 1994 and is based in Shanghai, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 600196.SHG using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025